Heyholder
‹ Activism Filings

Yuyu Pharma, Inc. Q3 revenue KRW 37.0 billion, operating profit KRW 3.3 billion, down 34.4% from a year earlier

Yuyu Pharma, Inc.· Periodic Report

AI summary · Not investment advice

In the third quarter, the company sold KRW 37.0 billion of goods and earned KRW 3.3 billion from its main business, down 34.4% from a year earlier and 18.3% from the prior quarter.

Operating profit · 3 months

KRW 3.3 billion

Key facts

Revenue (3 months)
KRW 37.0 billion
Net income (3 months)
KRW 2.5 billion
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 37.8 billion
Revenue (year to date)
KRW 109.2 billion
Operating profit (prior-year 3 months)
KRW 5.0 billion
Operating profit (year to date)
KRW 11.6 billion
Net income (prior-year 3 months)
KRW 4.3 billion
Net income (year to date)
KRW 9.4 billion

Commentary

AI commentary · Not investment advice

What happened

Yuyu Pharma filed its quarterly report for the third quarter of 2026, on a consolidated basis. Sales for the latest 3 months were KRW 36.98 billion. That is 2.1% lower than the same period a year earlier and 0.8% higher than the previous quarter.

In the company's terms

Operating profit (profit from the main business) for the 3 months was KRW 3.27 billion. That is 34.4% lower than a year earlier and 18.3% lower than the previous quarter. Net income (final profit after taxes and other costs) for the 3 months was KRW 2.48 billion. That is 42.7% lower than a year earlier and 30.4% lower than the previous quarter.

What changes for shareholders

For the cumulative period from January 1 to September 30, 2026, sales were KRW 109.22 billion. Operating profit was KRW 11.58 billion, and net income was KRW 9.38 billion.

Comments

No comments yet

Comments from shareholders will appear here.